How much is Aktis Oncology worth in 2026?

Aktis Oncology has a current valuation of N/A based on their Early Stage VC round and secondary market data.

How much funding has Aktis Oncology raised?

Aktis Oncology has raised $336.0M in total funding across 1 funding rounds.

Aktis Oncology

Drug DiscoveryWebsite

Aktis Oncology valuation and funding history | Last updated: September 20, 2024 | 1 funding rounds

Current Valuation

N/A

As of September 20, 2024

Total Funding Raised

$336.0M

Across 1 round

Last Round

Early Stage VC

$175.0M

Last Funding

Sep 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
September 20, 2024	Early Stage VC (Series B)	$175.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Aktis Oncology is currently valued at N/A as of September 20, 2024. The company has raised a total of $336.0M in funding across 1 funding round.

Track Aktis Oncology Valuation Updates

Get notified when Aktis Oncology raises new funding or valuation changes

Explore More Data

Detailed analysis for Aktis Oncology

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Aktis Oncology's valuation history, funding rounds, and growth metrics.

No credit card required

What is Aktis Oncology Worth in 2026?

Aktis Oncology is a leading private company in the Drug Discovery sector. Track Aktis Oncology's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Aktis Oncology Valuation is Determined

Private company valuations like Aktis Oncology's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.